Related references
Note: Only part of the references are listed.Small Cell Lung Cancer: Are We Making Progress?
Jonathan E. Dowell
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2010)
A Better Platinum-Based Anticancer Drug Yet to Come?
Ulrike Olszewski et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2010)
Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo
Ramon C. Sun et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
ERCC1 and Ki67 in Small Cell Lung Carcinoma and Other Neuroendocrine Tumors of the Lung Distribution and Impact on Survival
Birgit Guldhammer et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
In Vitro Chemoresistance Testing in Well-Differentiated Carcinoid Tumors
John M. Lyons et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
New-generation platinum agents for solid tumors
Neel Shah et al.
FUTURE ONCOLOGY (2009)
Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate
Shanta Dhar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The changing shape of mitochondrial apoptosis
Michal Wasilewski et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2009)
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
E. D. Michelakis et al.
BRITISH JOURNAL OF CANCER (2008)
Newer cytotoxic agents: Attacking cancer broadly
Beverly A. Teicher
CLINICAL CANCER RESEARCH (2008)
Quantitative evaluation of dichloroacetic acid kinetics in human - a physiologically based pharmacokinetic modeling investigation
Ting Li et al.
TOXICOLOGY (2008)
Typical and atypical carcinoid tumours:: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung
Mariano Garcia-Yuste et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2007)
Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors
Eduardo Vilar et al.
ENDOCRINE-RELATED CANCER (2007)
Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281
WJ Sun et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours
K Öberg et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Current status of gastrointestinal carcinoids
IM Modlin et al.
GASTROENTEROLOGY (2005)
Metastatic carcinoid tumors: A clinical review
JM Zuetenhorst et al.
ONCOLOGIST (2005)
Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours - A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS)
U Plockinger et al.
NEUROENDOCRINOLOGY (2004)
New chemotherapy agents for small cell lung cancer
K Kelly
CHEST (2000)
Share Paper
